The promotion of cervical cancer progression by signal transducer and activator of transcription 1-induced up-regulation of lncRNA MEOX2-AS1 as a competing endogenous RNA through miR-143-3p/VDAC1 pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet. 2019;393:169–182.
   PubMed Web of Science ®Google Scholar
• Sawaya GF, Smith-mccune K, Kuppermann M. Cervical cancer screening: more choices in 2019. Jama. 2019;321:2018–2019.
   PubMed Web of Science ®Google Scholar
• Otter SJ, Chatterjee J, Stewart AJ, et al. The role of biomarkers for the prediction of response to checkpoint immunotherapy and the rationale for the use of checkpoint immunotherapy in cervical cancer. Clin Oncol (R Coll Radiol). 2019;31:834–843.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Xu L, Simoens C, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;5:Cd009069.
   PubMed Web of Science ®Google Scholar
• Kaikkonen MU, Adelman K. Emerging Roles of Non-Coding RNA Transcription. Trends Biochem Sci. 2018;43:654–667.
   PubMed Web of Science ®Google Scholar
• Lorenzi L, Avila Cobos F, Decock A, et al. Long noncoding RNA expression profiling in cancer: challenges and opportunities. Genes Chromosomes Cancer. 2019;58:191–199.
   PubMed Web of Science ®Google Scholar
• St Laurent G, Wahlestedt C, Kapranov P. The Landscape of long noncoding RNA classification. Trends Genet. 2015;31:239–251.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253–1261.
   PubMed Web of Science ®Google Scholar
• Sun Q, Hao Q, Prasanth KV. Nuclear long noncoding RNAs: key regulators of gene expression. Trends Genet. 2018;34:142–157.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang C. Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer. Bioengineered. 2021;12:898–913.
   PubMed Web of Science ®Google Scholar
• Ouyang D, Su J, Huang P, et al. Identification of lncRNAs via microarray analysis for predicting HER2-negative breast cancer response to neoadjuvant chemotherapy. Int J Clin Exp Pathol. 2018;11:2621–2628.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lin Z, Zhang H, et al. Prediction of overall survival time in patients with colon adenocarcinoma using DNA methylation profiling of long non-coding RNAs. Oncol Lett. 2020;19:1496–1504.
   PubMed Web of Science ®Google Scholar
• Holmes ZE, Hamilton DJ, Hwang T, et al. The Sox2 transcription factor binds RNA. Nat Commun. 2020;11:1805.
   PubMed Web of Science ®Google Scholar
• Long Y, Wang X, Youmans DT, et al. How do lncRNAs regulate transcription? Sci Adv. 2017;3:eaao2110.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Esmaeili M, Taheri M. H19 lncRNA: roles in tumorigenesis. Biomed Pharmacother. 2020;123:109774.
   PubMed Web of Science ®Google Scholar
• Chi Y, Wang D, Wang J, et al. Long Non-Coding RNA in the pathogenesis of cancers. Cells. 2019;8;1015.
   Web of Science ®Google Scholar
• Chan JJ, Tay Y. Noncoding RNA:RNA regulatory networks in cancer. Int J Mol Sci. 2018;19;1310.
   Web of Science ®Google Scholar
• Lin LY, Yang L, Zeng Q, et al. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer. Mol Cancer. 2018;17:84.
   PubMed Web of Science ®Google Scholar
• Jiang H, Huang G, Zhao N, et al. Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p. J Exp Clin Cancer Res. 2018;37:169.
   PubMed Web of Science ®Google Scholar
• Chen S, Wang J. HAND2-AS1 inhibits invasion and metastasis of cervical cancer cells via microRNA-330-5p-mediated LDOC1. Cancer Cell Int. 2019;19:353.
   PubMed Web of Science ®Google Scholar
• Sun M, Nie FQ, Wang ZX, et al. Involvement of lncRNA dysregulation in gastric cancer. Histol Histopathol. 2016;31:33–39.
   PubMed Web of Science ®Google Scholar
• Chen Q, Hu L, Huang D, et al. Six-lncRNA immune prognostic signature for cervical cancer. Front Genet. 2020;11:533628.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yao Y, Jiang X, et al. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. J Exp Clin Cancer Res. 2018;37:81.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang B, Zhang H, et al. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway. Biochem Biophys Res Commun. 2019;512:150–155.
   PubMed Web of Science ®Google Scholar
• Liu C, Li X, Hao Y, et al. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis. Aging (Albany NY). 2020;12:8680–8701.
   PubMedGoogle Scholar
• Yang J, Liu Y, Mai X, et al. STAT1-induced upregulation of LINC00467 promotes the proliferation migration of lung adenocarcinoma cells by epigenetically silencing DKK1 to activate Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun. 2019;514:118–126.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–358.
   PubMed Web of Science ®Google Scholar
• Li P, Wang J, Zhi L, et al. Linc00887 suppresses tumorigenesis of cervical cancer through regulating the miR-454-3p/FRMD6-Hippo axis. Cancer Cell Int. 2021;21:33.
   PubMed Web of Science ®Google Scholar
• Xie F, Xie G, Sun Q. Long noncoding RNA DLX6-AS1 promotes the progression in cervical cancer by targeting miR-16-5p/ARPP19 axis. Cancer Biother Radiopharm. 2020;35:129–136.
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52:710–718.
   PubMed Web of Science ®Google Scholar
• Xu R, Zhang X, Xu Y, et al. Long noncoding RNA MST1P2 promotes cervical cancer progression by sponging with microRNA miR-133b. Bioengineered. 2021;12:1851–1860.
   PubMed Web of Science ®Google Scholar
• Song L, Wang L, Pan X, et al. lncRNA OIP5-AS1 targets ROCK1 to promote cell proliferation and inhibit cell apoptosis through a mechanism involving miR-143-3p in cervical cancer. Braz J Med Biol Res = Rev Bras Pesqui Med Biol. 2020;53:e8883.
   PubMed Web of Science ®Google Scholar
• Xie F, Li C, Zhang X, et al. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS. Biomed Pharmacother. 2019;119:109424.
   PubMed Web of Science ®Google Scholar
• Acunzo M, Romano G, Wernicke D, et al. MicroRNA and cancer--a brief overview. Adv Biol Regul. 2015;57:1–9.
   PubMedGoogle Scholar
• Zhang X, Zhao X, Li Y, et al. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1. J Cell Physiol. 2019;234:17494–17504.
   PubMed Web of Science ®Google Scholar
• Zhang C, Hua Y, Qiu H, et al. KMT2A regulates cervical cancer cell growth through targeting VDAC1. Aging (Albany NY). 2020;12:9604–9620.
   PubMedGoogle Scholar